本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pyxis Oncology, Inc.

3.21
-0.0600-1.83%
盤後3.270.0600+1.87%19:42 EDT
成交量:112.95萬
成交額:358.12萬
市值:2.68億
市盈率:-2.29
高:3.42
開:3.31
低:3.07
收:3.27
52周最高:5.55
52周最低:1.03
股本:8,340.81萬
流通股本:4,956.07萬
量比:0.59
換手率:2.28%
股息:- -
股息率:- -
每股收益(TTM):-1.4029
每股收益(LYR):-1.2813
淨資產收益率:-179.10%
總資產收益率:-62.95%
市淨率:23.40
市盈率(LYR):-2.51

資料載入中...

2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/29

SEC問詢函

Form CORRESP - Correspondence
2023/08/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/23

重要事件披露

Form 8-K - Current report
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/11

重要事件披露

Form 8-K - Current report